Search result for Oxford University
S. KOREA RECEIVES NEW BATCH OF ASTRAZENECA COVID-19 VACCINES
Highlights –
- S. Korea receives new batch of AstraZeneca COVID-19 vaccines.
- S. Korea received new 835,000 doses of AstraZeneca's COVID-19 vaccines.
- S. Korea vaccinated a total of 3.71 million people, or 7.2 percent of the populatio...
NEW DATA SHOWS ASTRAZENECA COVID-19 VACCINE IS 76% EFFECTIVE
Highlights
• The UK-based drugmaker AstraZeneca on Thursday said its vaccine was 76% effective at preventing symptomatic illness
• AstraZeneca on Thursday also reiterated the coronavirus developed by them along with the University of Oxford was 100% effective against...
AstraZeneca, JOHNSON & JOHNSON RESUME COVID VACCINE TRIALS IN U.S.
Highlights
• AstraZeneca said the Food and Drug Administration (FDA) today authorized the restart in the U.S., following the resumption of trials in other countries in recent weeks
• The drugmaker further said that the FDA reviewed all safety data from trials globall...
ASTRAZENECA US COVID-19 VACCINE TRIAL LIKELY TO RESUME THIS WEEK
Highlights
• Late-stage US trial of AstraZeneca's COVID-19 vaccine were put on hold since September 6 after a participant in the company’s UK trial fell ill with a suspiciously rare spinal inflammatory disorder known as transverse myelitis
• Sources claim t...
US LIKELY TO BUY ALL DOSES OF UK’S AstraZeneca-OXFORD COVID-19 VACCINE
Highlights
• The US President Donald Trump has directed defence and health chiefs to ensure that the US is the first in the list to get UK's COVID-19 vaccine currently developed by pharmaceutical company AstraZeneca along with the University of Oxford
• The Ameri...
FDA REPORTEDLY EXPANDING ITS INVESTIGATION OF ASTRAZENECA COVID-19 VACCINE TRIAL
Highlights
• Reports state that by expanding its probe into the unexplained illness, the FDA will be looking into trials conducted at earlier stages of similar vaccines developed by the same scientists
• One of the source has claimed that with this investigation, the...
COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY
According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to det...
COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK
Highlights
• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford
• On Monday, the national expert group on vacci...
COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE
Highlights
• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII
• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford
• Before starting the phase 3 tria...
JAPAN WANTS TO SECURE CORONAVIRUS VACCINE
HIGHLIGHTS
- Daiichi Sankyo is talking to AstraZeneca to secure Japan supplies of a potential coronavirus vaccine.
- The vaccine is called AZD1222.
Japanese pharmaceutical company Daiichi Sankyo is in discussions with British pharmaceuti...